I migliori medici di Resezione del cancro del colon in Israele — TOP-12 medici

Esperto di spicco in oncologia dei sarcomi e delle ossa presso il Sourasky Medical Center con oltre 25 anni di esperienza specializzata.

• Direttore dell'Unità di Oncologia dei Tessuti Molli e delle Ossa
• Formazione di fellowship presso l'Institut Gustave Roussy a Parigi
• Membro attivo della Sarcoma Faculty di ESMO
• Ha pubblicato ampiamente sull'immunologia tumorale

La Dott.ssa Pelles Sharon è specializzata nel trattamento del cancro del colon presso il Sourasky Medical Center, combinando l'esperienza chirurgica con tecniche avanzate come HIPEC e l'immunoterapia.

• Ampia esperienza in interventi chirurgici per il cancro del colon, incluse colectomie e resezioni rettali
• Pioniera della Chemioterapia Intraoperatoria Ipertermica (HIPEC) per casi avanzati
• Guidata la ricerca clinica su atteggiamenti dei pazienti verso le sperimentazioni sul cancro
• Offre un approccio completo con chirurgia, radioterapia e terapie mirate

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Il dottor Riad Hadad è un rinomato chirurgo e oncologo israeliano. È specializzato nel trattamento chirurgico dei tumori del tratto gastrointestinale e del fegato.

Istruzione ed esperienza professionale

• Facoltà di Medicina, Istituto di Medicina Technion a Haifa, Israele;
• Tirocinio presso il Centro Medico Carmel, Haifa, Israele;
• specializzazione in chirurgia generale presso l'Università di Tel Aviv, Israele;
• specializzazione nel campo dell'oncologia del tratto gastrointestinale e del fegato presso il centro medico dell'Università di Toronto, Canada;
• Oggi, il dottor Hadad dirige il dipartimento per il trattamento del fegato, del pancreas e della cistifellea presso la Clinica Assuta.

Attività scientifica

Il dottor Riad Hadad è autore di 60 pubblicazioni scientifiche ed è relatore in simposi e conferenze internazionali.

Appartenenza a associazioni internazionali

• Associazione Medica Israeliana;
• Società Chirurgica Israeliana;
• Società Israeliana di Oncologia Chirurgica;
• Associazione degli Oncologi Chirurgici;
• Società Europea di Oncologia Chirurgica;
• Associazione Europea Epatopancreatobiliare.